Almac Group Ltd - Strategic SWOT Analysis Review
Almac Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Almac Group Ltd (Almac) is a contract development and manufacturing organization. It provides integrated services to pharmaceutical and biotechnology companies. The company offers a comprehensive range of services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to commercialization of products. Its services portfolio encompass diagnostics and biomarker development, clinical technologies, Active Pharmaceutical Ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina and Pennsylvania in the US and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.
Almac Group Ltd Key Recent Developments
Jul 29,2021: THREAD and Almac collaborate to lower trial delays
May 25,2021: Almac Group invests ?325,000 as part of Stage 1 entry into continuous flow manufacturing
Mar 25,2021: Almac Group awarded ISO certification for Integrated Safety and Environment Management System
Mar 01,2021: Almac Clinical Technologies Appoints Abi Pesun as Vice President of UK Operations
Feb 23,2021: Almac Group completes ?5million research & development centre
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Almac Group Ltd (Almac) is a contract development and manufacturing organization. It provides integrated services to pharmaceutical and biotechnology companies. The company offers a comprehensive range of services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to commercialization of products. Its services portfolio encompass diagnostics and biomarker development, clinical technologies, Active Pharmaceutical Ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina and Pennsylvania in the US and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.
Almac Group Ltd Key Recent Developments
Jul 29,2021: THREAD and Almac collaborate to lower trial delays
May 25,2021: Almac Group invests ?325,000 as part of Stage 1 entry into continuous flow manufacturing
Mar 25,2021: Almac Group awarded ISO certification for Integrated Safety and Environment Management System
Mar 01,2021: Almac Clinical Technologies Appoints Abi Pesun as Vice President of UK Operations
Feb 23,2021: Almac Group completes ?5million research & development centre
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
SECTION 1 - ABOUT THE COMPANY
Almac Group Ltd - Key Facts
Almac Group Ltd - Key Employees
Almac Group Ltd - Key Employee Biographies
Almac Group Ltd - Major Products and Services
Almac Group Ltd - History
Almac Group Ltd - Company Statement
Almac Group Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Almac Group Ltd - Business Description
Almac Group Ltd - SWOT Analysis
SWOT Analysis - Overview
Almac Group Ltd - Strengths
Almac Group Ltd - Weaknesses
Almac Group Ltd - Opportunities
Almac Group Ltd - Threats
Almac Group Ltd - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Almac Group Ltd, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Jul 29, 2021: THREAD and Almac collaborate to lower trial delays
May 25, 2021: Almac Group invests ?325,000 as part of Stage 1 entry into continuous flow manufacturing
Mar 25, 2021: Almac Group awarded ISO certification for Integrated Safety and Environment Management System
Mar 01, 2021: Almac Clinical Technologies Appoints Abi Pesun as Vice President of UK Operations
Feb 23, 2021: Almac Group completes ?5million research & development centre
Jan 12, 2021: Almac Group awarded ?Multimillion R&D grant to accelerate enzyme discovery unique INSIGHT project builds on Almac’s existing enzyme expertise
Oct 07, 2020: Almac Group appoints Vice President of Small Molecule API
Sep 24, 2020: Almac Group launches biologics testing solutions
Sep 02, 2020: Almac Group donates a quarter of a million pounds to global charities in wake of COVID-19
Jul 21, 2020: Almac Group announces winners of claraT Grant Programme for Academia
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
Almac Group Ltd - Key Facts
Almac Group Ltd - Key Employees
Almac Group Ltd - Key Employee Biographies
Almac Group Ltd - Major Products and Services
Almac Group Ltd - History
Almac Group Ltd - Company Statement
Almac Group Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Almac Group Ltd - Business Description
Almac Group Ltd - SWOT Analysis
SWOT Analysis - Overview
Almac Group Ltd - Strengths
Almac Group Ltd - Weaknesses
Almac Group Ltd - Opportunities
Almac Group Ltd - Threats
Almac Group Ltd - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Almac Group Ltd, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Jul 29, 2021: THREAD and Almac collaborate to lower trial delays
May 25, 2021: Almac Group invests ?325,000 as part of Stage 1 entry into continuous flow manufacturing
Mar 25, 2021: Almac Group awarded ISO certification for Integrated Safety and Environment Management System
Mar 01, 2021: Almac Clinical Technologies Appoints Abi Pesun as Vice President of UK Operations
Feb 23, 2021: Almac Group completes ?5million research & development centre
Jan 12, 2021: Almac Group awarded ?Multimillion R&D grant to accelerate enzyme discovery unique INSIGHT project builds on Almac’s existing enzyme expertise
Oct 07, 2020: Almac Group appoints Vice President of Small Molecule API
Sep 24, 2020: Almac Group launches biologics testing solutions
Sep 02, 2020: Almac Group donates a quarter of a million pounds to global charities in wake of COVID-19
Jul 21, 2020: Almac Group announces winners of claraT Grant Programme for Academia
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Almac Group Ltd, Key Facts
Almac Group Ltd, Key Employees
Almac Group Ltd, Key Employee Biographies
Almac Group Ltd, Major Products and Services
Almac Group Ltd, History
Almac Group Ltd, Other Locations
Almac Group Ltd, Subsidiaries
Almac Group Ltd, Key Competitors
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Almac Group Ltd, Recent Deals Summary
Almac Group Ltd, Key Facts
Almac Group Ltd, Key Employees
Almac Group Ltd, Key Employee Biographies
Almac Group Ltd, Major Products and Services
Almac Group Ltd, History
Almac Group Ltd, Other Locations
Almac Group Ltd, Subsidiaries
Almac Group Ltd, Key Competitors
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Almac Group Ltd, Recent Deals Summary
LIST OF FIGURES
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Almac Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021